Related Experiment Video
Updated: May 23, 2026
08:49
Assessing Changes in Volatile General Anesthetic Sensitivity of Mice after Local or Systemic Pharmacological Intervention
Published on: October 16, 2013
Pharmacogenetics and anesthetic drugs
Vidya Chidambaran1, Pornswan Ngamprasertwong, Alexander A Vinks
1Department of Anesthesiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio 45229-3039, USA. vidya.chidambaran@cchmc.org
Current Clinical Pharmacology
|March 22, 2012
Summary
Genetic factors significantly increase serious adverse drug reactions in anesthesia. Understanding pharmacogenetics is crucial for personalized perioperative care, but clinical implementation requires more robust data and study designs.
Area of Science:
- Anesthesiology
- Pharmacogenetics
- Genomics
Background:
- Serious adverse drug reactions (SADRs) in anesthesia are common due to narrow therapeutic indices and variable patient responses.
- Genetic factors are a major contributor to SADRs, with historical examples like succinylcholine apnea and malignant hyperthermia.
- Pharmacogenetics (PG) is increasingly recognized for its role in understanding anesthetic drug action.
Purpose of the Study:
- To review the history and current state of anesthetic pharmacogenetics.
- To discuss key genes, genetic variations, and their impact on anesthetic drug metabolism and response.
- To explore the potential clinical applications and current limitations in translating PG findings to anesthesia practice.
Main Methods:
- Literature review of historical and recent research in anesthetic pharmacogenetics.
- Discussion of genetic variations influencing anesthetic pharmacokinetics and pharmacodynamics.
- Exploration of epigenetics and functional genomics in relation to anesthesia.
Main Results:
- Genetic variations significantly affect how patients respond to anesthetic and analgesic drugs.
- Specific genes involved in anesthetic drug metabolism have been identified.
- Despite advances, significant knowledge gaps and challenges hinder clinical translation.
Conclusions:
- Pharmacogenetics offers significant potential for improving patient safety and tailoring anesthetic care.
- Robust clinical studies with large sample sizes and sound statistical analysis are essential for successful implementation.
- Future research must bridge the gap between genetic discoveries and routine clinical application in perioperative medicine.
Related Concept Videos
01:29Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
01:27Pharmacogenetics of Drug Metabolism: Overview
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
01:13Local Anesthetics: Pharmacokinetics
The potency and duration of action of local anesthetics (LAs) are determined by their pharmacokinetics. Pharmacokinetics describes how LAs are absorbed, distributed, metabolized, and eliminated from the body. When administered to the vascular tissues, LAs are quickly absorbed and enter the systemic circulation, reducing their localized effects. Adding vasoconstrictors such as epinephrine to LAs reduces their absorption into the systemic circulation, making them clinically effective. The...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...